Axon Enterprise, Inc (NASDAQ:AXON) Position Decreased by Board of the Pension Protection Fund

Board of the Pension Protection Fund reduced its holdings in Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 45.5% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,200 shares of the biotechnology company's stock after selling 1,000 shares during the quarter. Board of the Pension Protection Fund's holdings in Axon Enterprise were worth $631,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also added to or reduced their stakes in AXON. Capital World Investors lifted its position in shares of Axon Enterprise by 86.4% during the 4th quarter. Capital World Investors now owns 1,815,765 shares of the biotechnology company's stock valued at $1,079,145,000 after acquiring an additional 841,772 shares during the last quarter. Alliancebernstein L.P. lifted its holdings in shares of Axon Enterprise by 273.8% during the fourth quarter. Alliancebernstein L.P. now owns 1,109,045 shares of the biotechnology company's stock valued at $659,128,000 after purchasing an additional 812,337 shares during the last quarter. Norges Bank acquired a new position in shares of Axon Enterprise in the 4th quarter valued at $482,081,000. GQG Partners LLC purchased a new position in Axon Enterprise in the 4th quarter worth about $478,349,000. Finally, GAMMA Investing LLC raised its holdings in Axon Enterprise by 58,725.5% during the 1st quarter. GAMMA Investing LLC now owns 764,731 shares of the biotechnology company's stock worth $402,210,000 after buying an additional 763,431 shares during the period. 79.08% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In other Axon Enterprise news, President Joshua Isner sold 905 shares of the business's stock in a transaction on Tuesday, June 17th. The shares were sold at an average price of $776.39, for a total transaction of $702,632.95. Following the completion of the transaction, the president now owns 268,735 shares of the company's stock, valued at $208,643,166.65. The trade was a 0.34% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CAO Jennifer H. Mak sold 75 shares of the stock in a transaction that occurred on Friday, June 13th. The shares were sold at an average price of $771.81, for a total value of $57,885.75. Following the sale, the chief accounting officer now owns 15,240 shares of the company's stock, valued at approximately $11,762,384.40. The trade was a 0.49% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 44,642 shares of company stock worth $30,500,428. 4.40% of the stock is currently owned by insiders.

Axon Enterprise Stock Up 2.4%

AXON opened at $803.95 on Friday. The company has a market capitalization of $62.59 billion, a PE ratio of 194.19, a price-to-earnings-growth ratio of 90.37 and a beta of 1.29. The company has a debt-to-equity ratio of 0.68, a current ratio of 2.83 and a quick ratio of 2.62. Axon Enterprise, Inc has a fifty-two week low of $279.02 and a fifty-two week high of $806.64. The business has a 50-day moving average of $709.79 and a 200-day moving average of $629.30.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last posted its earnings results on Wednesday, May 7th. The biotechnology company reported $1.41 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.34 by $0.07. Axon Enterprise had a net margin of 14.86% and a return on equity of 5.81%. The firm had revenue of $603.63 million during the quarter, compared to analysts' expectations of $585.67 million. During the same period in the previous year, the company earned $1.15 earnings per share. The company's revenue was up 31.3% compared to the same quarter last year. Equities research analysts forecast that Axon Enterprise, Inc will post 5.8 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

AXON has been the subject of several recent analyst reports. Bank of America raised their target price on shares of Axon Enterprise from $750.00 to $895.00 and gave the stock a "buy" rating in a report on Wednesday, June 4th. The Goldman Sachs Group raised their price objective on shares of Axon Enterprise from $730.00 to $830.00 and gave the stock a "buy" rating in a research note on Wednesday, May 14th. Needham & Company LLC boosted their target price on shares of Axon Enterprise from $600.00 to $750.00 and gave the company a "buy" rating in a research note on Thursday, May 8th. Barclays raised their target price on Axon Enterprise from $726.00 to $735.00 and gave the stock an "overweight" rating in a research report on Friday, May 9th. Finally, Craig Hallum downgraded Axon Enterprise from a "buy" rating to a "cautious" rating in a research note on Monday, March 10th. One research analyst has rated the stock with a sell rating, one has given a hold rating and ten have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $699.55.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.